Sheng Ping Zhong
Fortuna: 32 M $ al 30/09/2026
Fortuna: 32 M $ al 30/09/2026
Sheng Ping Zhong is the founder and current General Manager of Jinshi Biotechnology (Changsu) Co., Ltd. which is founded in 2012.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Zylox-Tonbridge Medical Technology Co., Ltd.
Zylox-Tonbridge Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Manufactures and sells medical devices 3,41 % | 02/04/2026 | 11.476.617 ( 3,41 % ) | 32 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Jinshi Biotechnology (Changsu) Co., Ltd.
Jinshi Biotechnology (Changsu) Co., Ltd. Medical SpecialtiesHealth Technology Researches, develops and produces surgical products | Director Ejecutivo | 16/04/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 1 |
|---|---|
Jinshi Biotechnology (Changsu) Co., Ltd.
Jinshi Biotechnology (Changsu) Co., Ltd. Medical SpecialtiesHealth Technology Researches, develops and produces surgical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.